Nearly two-thirds of the population in Switzerland supports the idea of legalizing cannabis for recreational purposes on the condition that there are rules to protect minors, the results of a survey indicate.
The Sotomo Institute, mandated by the Federal Office of Public Health (FOPH), conducted the survey representative from January to April 2021 in which 3166 persons of legal age participated.
Representatives of the OFSP and the authors of the survey released the results on July 1st in Bern during a press conference.
67% of the people who participated in the survey are in favor of the Swiss authorities conducting pilot tests on the controlled distribution of cannabis for recreational purposes. Specifically, they responded to the question, “At last fall’s session, Parliament decided to allow the experimental distribution of cannabis for consumption purposes to a limited number of people within the framework of scientific research. Do you support this project?”
Read more about the latest survey on the legalization of cannabis in Switzerland and find the most important cannabis news with the Hemp.im mobile app.
The main reason why Swiss people are fro cannabis legalization is for its medical properties
78% of the survey participants support the legalization of cannabis in Switzerland for medicinal purposes and nearly 70% consider it necessary to reform the law concerning cannabis in Switzerland, under the arguments of limiting the black market and improving consumer protection.
Opponents of cannabis legalization say they are concerned about the effects of this drug on the brains of young people. In this sense, they consider necessary measures such as a strict protection of minors, the prohibition of advertising and the establishment of a high tax rate for cannabis products.
At the press conference, representatives of the OFSP discussed the current situation regarding the consumption of this plant in Switzerland, despite the fact that it has been classified as a prohibited drug since 1951.
Law and reality
In principle, it cannot be cultivated, produced, or sold. In 1975, consumption also became a punishable offense. But the reality of its use is different.
“Cannabis use is too widespread in Switzerland for prohibition to still make sense,” Adrian Gschwend, head of the Political Foundations and Law Enforcement Section of the Federal Office of Public Health (FOPH), said on Thursday.
Every day, 750,000 cannabis cigarettes are smoked and the number of regular users is estimated at 220,000.
The federal government spends $129.7 million (120 million Swiss francs) a year trying to enforce the ban, but without being able to curb cannabis use, Gschwend said.
At the same time, he said, the black market flourishes because of the ban. This generates a turnover in Switzerland of approximately $629 million (582 million francs) annually, warned the expert citing the results of a study by the University of Geneva that has not yet been publicly released.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in SWI swissinfo.ch, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Mozambique/Debt: Credit Suisse Pleads Guilty and Pays $475 million
Credit Suisse bank has pleaded guilty to conspiracy to commit fraudulent financial transfer by paying $475 million in a settlement...
Virtual and Augmented Reality Are Shaking Up the Education Experience
While virtual and augmented reality are making a big impact in all manner of fields, education is one sector that...
MicroStrategy Stock Could Fall 12% after Bitcoin ETF Launch
MicroStrategy's revenue has dropped from more than $513 million in 2017 to more than $480 million in 2020. Profits have...
Atrys Health Increases Sales Fivefold in the First Half of 2021
Atrys Health presents its financial results for the first six months of 2021 while announcing that it has reached an...
Medical Cannabis To Be Sold Freely in Drugstores across Colombia
The Colombian Association of Cannabis Industries, Asocolcanna, indicated that the potential of this market is great since the country went...
Cannabis2 weeks ago
Malta Might Soon Legalize Private Cannabis Consumption
Featured2 weeks ago
Why an Energy Crunch is Most Likely Coming
Featured2 weeks ago
Small Businesses in Colombia Benefit From the Development of the Fintech Sector
Cannabis2 weeks ago
ArgenCann Will Be Part of Expo Cannabis 2021